New York Life Investment Management LLC Century Therapeutics, Inc. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$1.28 - $3.32 $3,448 - $8,944
-2,694 Reduced 2.63%
99,912 $331,000
Q3 2023

Nov 07, 2023
SELL
$2.0 - $3.23 $32,330 - $52,212
-16,165 Reduced 13.61%
102,606 $205,000
Q2 2023

Aug 04, 2023
SELL
$2.91 - $3.53 $43,818 - $53,154
-15,058 Reduced 11.25%
118,771 $375,000
Q1 2023

May 08, 2023
BUY
$3.4 - $5.11 $455,018 - $683,866
133,829 New
133,829 $464,000

Others Institutions Holding IPSC

# of Institutions
66
Shares Held
36.9M
Call Options Held
8.7K
Put Options Held
10.2K
View Full List

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $61.8M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email